Please use this identifier to cite or link to this item: http://192.168.1.35:80/jspui/handle/Hannan/32348
Title: Impact of Ghrelin on Body Composition and Muscle Function in a Long-Term Rodent Model of Critical Illness
Authors: Ministry Of Defence;Hill, NE;Murphy, KG;Saeed, S;Phadke, R;Chambers, D;Wilson, DR;Brett, SJ;Singer, M
subject: Science & Technology
Multidisciplinary Sciences
Science & Technology - Other Topics
PLACEBO-CONTROLLED TRIAL
FOOD-INTAKE
THERMAL-INJURY
HEART-FAILURE
ILL ADULTS
RAT MODEL
CACHEXIA
NUTRITION
SEPSIS
METABOLISM
MD Multidisciplinary
General Science & Technology
Year: 6-Sep-2017
Publisher: Public Library of Science
Description: Background Patients with multiple injuries or sepsis requiring intensive care treatment invariably develop a catabolic state with resultant loss of lean body mass, for which there are currently no effective treatments. Recovery can take months and mortality is high. We hypothesise that treatment with the orexigenic and anti-inflammatory gastric hormone, ghrelin may attenuate the loss of body mass following critical illness and improve recovery. Methods Male Wistar rats received an intraperitoneal injection of the fungal cell wall derivative zymosan to induce a prolonged peritonitis and consequent critical illness. Commencing at 48h after zymosan, animals were randomised to receive a continuous infusion of ghrelin or vehicle control using a pre-implanted subcutaneous osmotic mini-pump, and continued for 10 days. Results Zymosan peritonitis induced significant weight loss and reduced food intake with a nadir at Day 2 and gradual recovery thereafter. Supra-physiologic plasma ghrelin levels were achieved in the treated animals. Ghrelin-treated rats ate more food and gained more body mass than controls. Ghrelin increased adiposity and promoted carbohydrate over fat metabolism, but did not alter total body protein, muscle strength nor muscle morphology. Muscle mass and strength remained significantly reduced in all zymosan-treated animals, even at ten days post-insult. Conclusions Continuous infusion of ghrelin increased body mass and food intake, but did not increase muscle mass nor improve muscle function, in a long-term critical illness recovery model. Further studies with pulsatile ghrelin delivery or additional anabolic stimuli may further clarify the utility of ghrelin in survivors of critical illness.
URI: http://localhost/handle/Hannan/32348
https://spiral.imperial.ac.uk:8443/handle/10044/1/50221
Standard no: 1932-6203
https://dx.doi.org/10.1371/journal.pone.0182659
RCDM/Res/1034/7/3
Type Of Material: Article
Appears in Collections:Department of Surgery and Cancer

Files in This Item:
Click on the URI links for accessing contents.


Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.